Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPAL trial of oxycodone for acute low back pain and/or neck pain
ACTRN12615000775516Phase 4Completed
- Sponsor
- The George Institute for Global Health
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial in acute lumbago and neck pain comparing Modified-release oxycodone + guideline care with Placebo + guideline care (2 arms). Primary endpoint: Pain severity. Started Feb 2016; status: completed.
02
Drugs
oxycodone
03
Conditions
acute lumbagoneck pain
Beyond the preview
Go deeper on ACTRN12615000775516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000775516.